BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25412779)

  • 21. Cellular dissection of psoriasis for transcriptome analyses and the post-GWAS era.
    Swindell WR; Stuart PE; Sarkar MK; Voorhees JJ; Elder JT; Johnston A; Gudjonsson JE
    BMC Med Genomics; 2014 May; 7():27. PubMed ID: 24885462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular dissection of psoriasis: integrating genetics and biology.
    Elder JT; Bruce AT; Gudjonsson JE; Johnston A; Stuart PE; Tejasvi T; Voorhees JJ; Abecasis GR; Nair RP
    J Invest Dermatol; 2010 May; 130(5):1213-26. PubMed ID: 19812592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double-stranded RNA in disease pathogenesis.
    Bijlmakers MJ; Kanneganti SK; Barker JN; Trembath RC; Capon F
    Hum Mol Genet; 2011 Aug; 20(16):3129-37. PubMed ID: 21571784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psoriasis, innate immunity, and gene pools.
    Bos JD
    J Am Acad Dermatol; 2007 Mar; 56(3):468-71. PubMed ID: 17317489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis.
    Sun L; Liu W; Zhang LJ
    J Immunol Res; 2019; 2019():1824624. PubMed ID: 31815151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes.
    Nomura I; Goleva E; Howell MD; Hamid QA; Ong PY; Hall CF; Darst MA; Gao B; Boguniewicz M; Travers JB; Leung DY
    J Immunol; 2003 Sep; 171(6):3262-9. PubMed ID: 12960356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics of psoriasis: evidence for epistatic interaction between skin barrier abnormalities and immune deviation.
    Bergboer JGM; Zeeuwen PLJM; Schalkwijk J
    J Invest Dermatol; 2012 Oct; 132(10):2320-2331. PubMed ID: 22622420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NK cells and psoriasis.
    Dunphy S; Gardiner CM
    J Biomed Biotechnol; 2011; 2011():248317. PubMed ID: 21687543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Keratinocyte Transcriptome in Psoriasis: Pathways Related to Immune Responses, Cell Cycle and Keratinization.
    Pasquali L; Srivastava A; Meisgen F; Das Mahapatra K; Xia P; Xu Landén N; Pivarcsi A; Sonkoly E
    Acta Derm Venereol; 2019 Feb; 99(2):196-205. PubMed ID: 30320872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From Empirical to Pathogenesis-Based Treatments for Psoriasis.
    van de Kerkhof PC
    J Invest Dermatol; 2022 Jul; 142(7):1778-1785. PubMed ID: 35249726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The current landscape of psoriasis genetics in 2020.
    Ogawa K; Okada Y
    J Dermatol Sci; 2020 Jul; 99(1):2-8. PubMed ID: 32536600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signs of innate immune activation and premature immunosenescence in psoriasis patients.
    Šahmatova L; Sügis E; Šunina M; Hermann H; Prans E; Pihlap M; Abram K; Rebane A; Peterson H; Peterson P; Kingo K; Kisand K
    Sci Rep; 2017 Aug; 7(1):7553. PubMed ID: 28790368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional Genomics and Insights into the Pathogenesis and Treatment of Psoriasis.
    Shellard EM; Rane SS; Eyre S; Warren RB
    Biomolecules; 2024 May; 14(5):. PubMed ID: 38785955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic risk factors for the development of allergic disease identified by genome-wide association.
    Portelli MA; Hodge E; Sayers I
    Clin Exp Allergy; 2015 Jan; 45(1):21-31. PubMed ID: 24766371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psoriasis.
    Nestle FO; Kaplan DH; Barker J
    N Engl J Med; 2009 Jul; 361(5):496-509. PubMed ID: 19641206
    [No Abstract]   [Full Text] [Related]  

  • 36. Leprosy susceptibility: genetic variations regulate innate and adaptive immunity, and disease outcome.
    Cardoso CC; Pereira AC; de Sales Marques C; Moraes MO
    Future Microbiol; 2011 May; 6(5):533-49. PubMed ID: 21585261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The new insight into the role of antimicrobial proteins-alarmins in the immunopathogenesis of psoriasis.
    Batycka-Baran A; Maj J; Wolf R; Szepietowski JC
    J Immunol Res; 2014; 2014():628289. PubMed ID: 24901012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Epigenetic Factors in the Pathogenesis of Psoriasis.
    Olejnik-Wojciechowska J; Boboryko D; Bratborska AW; Rusińska K; Ostrowski P; Baranowska M; Pawlik A
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of human 6-sulfo LacNAc dendritic cells (slanDCs) in autoimmunity and tumor diseases].
    Döbel T; Schäkel K
    J Dtsch Dermatol Ges; 2014 Oct; 12(10):874-80. PubMed ID: 25262889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of adalimumab on key drivers in the pathogenesis of psoriasis.
    Hendriks AG; van der Velden HM; Wolberink EA; Seyger MM; Schalkwijk J; Zeeuwen PL; de Jong EM; Pasch MC; van Erp PE; van de Kerkhof PC
    Br J Dermatol; 2014 Mar; 170(3):571-80. PubMed ID: 24640989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.